Incidence and treatment of procedural cardiovascular complications associated with trans-arterial and trans-apical interventional aortic valve implantation in 412 consecutive patients
Key result
Trans-catheter aortic valve implantation in 412 patients resulted in a 30-day survival of 90.9%, with vascular complications in 10.2% and a reduction in complications seen after 300 cases.
Why the study?
What is the incidence of procedural cardiovascular complications associated with TAVI in a high-risk patient cohort?
Population
412 patients undergoing trans-catheter aortic valve implantation, mean age 80.3±7.2 years, 258 female…
Design
Cohort
Follow-up
30-day
Authors
Discussion
Loading...
Member takes
Implication
TAVI vascular complications may decline after 300 cases in high-risk cohorts; leaves open optimal volume thresholds for certification.
Study Design
Type
Cohort (n=412)
Multicenter
No
Structured PICO
What is the incidence of procedural cardiovascular complications associated with TAVI in a high-risk patient cohort?
P
Population
412 patients undergoing trans-catheter aortic valve implantation (TAVI), mean age 80.3±7.2 years, 258 female, logistic EuroSCORE 20.2%±13.0%.
I
Intervention
Trans-catheter aortic valve implantation (TAVI) via retrograde (n=285) or antegrade trans-apical (n=127) approach using CoreValve (n=283) or Edwards Sapien (n=129) prostheses.
O
Outcome
Procedural cardiovascular complications and 30-day survivalsafety
TAVI is associated with significant procedural complications that decrease with institutional experience, highlighting the need for a multidisciplinary team in a hybrid operating room.
Cite This Study
Lange et al. (2011) conducted a cohort in Aortic valve disease requiring TAVI (n=412). Trans-catheter aortic valve implantation (TAVI) was evaluated on 30-day survival. Trans-catheter aortic valve implantation in 412 patients resulted in a 30-day survival of 90.9%, with vascular complications in 10.2% and a reduction in complications seen after 300 cases.